Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03682068
Brief Title: Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer (NILE)

First Submitted : September 6, 2018
First Submitted that Met QC Criteria : September 21, 2018
First Posted : September 24, 2018

Last Update Submitted that Met QC Criteria : May 28, 2021
Last Update Posted : June 1, 2021